Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Malignant Neurilemmoma

fluorodeoxyglucose f18 has been researched along with Malignant Neurilemmoma in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's2 (25.00)24.3611
2020's5 (62.50)2.80

Authors

AuthorsStudies
Li, L; Li, Y; Xiao, L1
Dong, Z; Guo, Z; Liu, W; Xie, P; Yang, L1
Kumar, R; Pandey, AK; Rastogi, S; Shamim, SA; Upadhyay, DMR; Yadav, D1
Butler, E; Geboers, S; Hao, G; Kim, J; Laetsch, TW; Nham, K; Schwettmann, B; Skapek, SX; Sun, X; Williams, NS; Xu, L1
Coert, JH; Geitenbeek, RTJ; Graven, LH; Grünhagen, DJ; Hanff, DF; Martin, E; Taal, W; Verhoef, C1
Kumar, R; Passah, A; Prashanth, A; Singhal, A; Tripathy, S1
Liu, C; Liu, E; Sun, T; Wang, S1
Carreras-Delgado, JL; Hornedo-Muguiro, J; Lapeña-Gutiérrez, L; Montz-Andrée, R; Pérez-Castejón, MJ; Ruíz-Hernández, G; Salinas-Hernández, P1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and Malignant Neurilemmoma

ArticleYear
A Bayesian approach for diagnostic accuracy of malignant peripheral nerve sheath tumors: a systematic review and meta-analysis.
    Neuro-oncology, 2021, 04-12, Volume: 23, Issue:4

    Topics: Bayes Theorem; Fluorodeoxyglucose F18; Humans; Nerve Sheath Neoplasms; Neurofibrosarcoma; Positron-Emission Tomography; Radiopharmaceuticals

2021

Other Studies

7 other study(ies) available for fluorodeoxyglucose f18 and Malignant Neurilemmoma

ArticleYear
Solitary Lymph Node Metastasis From a Malignant Peripheral Nerve Sheath Tumor of the Thoracic Vertebra Revealed on FDG PET/CT.
    Clinical nuclear medicine, 2022, May-01, Volume: 47, Issue:5

    Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Neurofibrosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Thoracic Vertebrae

2022
Solitary Malignant Peripheral Nerve Sheath Tumor of Lumbar Vertebra Mimicking Metastatic Malignancy.
    Clinical nuclear medicine, 2023, May-01, Volume: 48, Issue:5

    Topics: Aged; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Male; Neoplasms; Neoplasms, Second Primary; Nerve Sheath Neoplasms; Neurofibrosarcoma; Positron Emission Tomography Computed Tomography

2023
Role of 18F-FDG PET/computed tomography in prognostication and management of malignant peripheral nerve sheath tumors.
    Nuclear medicine communications, 2020, Volume: 41, Issue:9

    Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibrosarcoma; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Young Adult

2020
Functional imaging of RAS pathway targeting in malignant peripheral nerve sheath tumor cells and xenografts.
    Pediatric blood & cancer, 2020, Volume: 67, Issue:12

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzimidazoles; Cell Proliferation; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neurofibrosarcoma; Positron Emission Tomography Computed Tomography; Pyridones; Pyrimidinones; Radiopharmaceuticals; ras Proteins; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2020
Malignant Peripheral Nerve Sheath Tumor With Bilateral Adrenal Metastases: Role of 18F-FDG PET/CT in Response Assessment to Tyrosine Kinase Inhibitor and Liposomal Doxorubicin.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:6

    Topics: Adrenal Gland Neoplasms; Aged, 80 and over; Antineoplastic Agents; Doxorubicin; Fluorodeoxyglucose F18; Humans; Male; Nerve Sheath Neoplasms; Neurofibrosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2019
Giant Melanotic Malignant Peripheral Nerve Sheath Tumor in the Pelvis: Contrast-Enhanced CT and 18F-FDG PET/CT Finding.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:11

    Topics: Adult; Contrast Media; Fluorodeoxyglucose F18; Humans; Male; Neurofibrosarcoma; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography

2019
[Positron emission tomography in a patient with Von Recklinghausen disease and left dorsal neurofibrosarcoma].
    Revista espanola de medicina nuclear, 2003, Volume: 22, Issue:6

    Topics: Adult; Back; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neurofibromatosis 1; Neurofibrosarcoma; Radiopharmaceuticals; Soft Tissue Neoplasms; Spinal Cord Compression; Tomography, Emission-Computed

2003